Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment.

ABSTRACT: Recent progressions in immunotherapy have transformed cancer treatment, providing a promising strategy that activates the immune system of the patient to find and eliminate cancerous cells. Bispecific antibodies, which engage two separate antigens or one antigen with two distinct epitopes, are of tremendous concern in immunotherapy. The bi-targeting idea enabled by bispecific antibodies (BsAbs) is especially attractive from a medical standpoint since most diseases are complex, involving several receptors, ligands, and signaling pathways. Several research look into the processes in which BsAbs identify different cancer targets such angiogenesis, reproduction, metastasis, and immune regulation. By rerouting cells or altering other pathways, the bispecific proteins perform effector activities

SUBMITTER: Guo X 

PROVIDER: S-EPMC10722299 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature